Global Health Limited

NSE MEDANTA.NS

Global Health Limited EBIT Margin for the year ending March 31, 2024: 21.35%

Global Health Limited EBIT Margin is 21.35% for the year ending March 31, 2024, a 8.88% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Global Health Limited EBIT Margin for the year ending March 31, 2023 was 19.60%, a 20.89% change year over year.
Global Health Limited EBIT Margin for the year ending March 31, 2022 was 16.22%, a 120.72% change year over year.
Global Health Limited EBIT Margin for the year ending March 31, 2021 was 7.35%, a -9.58% change year over year.
Global Health Limited EBIT Margin for the year ending March 31, 2020 was 8.12%, a -3.16% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

NSE: MEDANTA.NS

Global Health Limited

CEO	Mr. Pankaj Prakash Sahni
IPO Date	Nov. 18, 2022
Location	India
Headquarters	The Medicity
Employees	9,052
Sector	Health Care
Industries Hospitals & Clinics Pharmaceuticals Telehealth

Description

Global Health Limited, a multi-specialty tertiary care provider, offers healthcare services in India. The company primarily offers treatments in the areas of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. It operates a network of four hospitals in Gurugram, Indore, Ranchi, and Lucknow under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurgaon, India.

Key trends

Past 5 years